6th Edition of Cardiology World Conference
September 15-17, 2025 | London, UK
Rheumatic Heart Disease
Rheumatic heart disease (RHD) continues to be a serious health issue, particularly in areas where access to healthcare is limited. It typically occurs after an individual contracts rheumatic fever, which is caused by an untreated streptococcal throat infection. The inflammation from rheumatic fever can result in long-term damage to the heart, especially affecting the heart valves, which may eventually lead to heart failure or other complications. Preventing RHD involves ensuring proper treatment of strep throat infections with antibiotics, as well as promoting early detection of any valve damage. With effective treatment and education, the global burden of rheumatic heart disease can be reduced, particularly in regions with higher rates of strep throat infections.
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Gustavo Lionel Knop
Mayo Clinic, United States
Arthur J Siegel
Massachusetts General Hospital, United States
Sekib Sokolovic
Sarajevo School of Science and Technology, Medical Faculty, ASA Hospital, Bosnia and Herzegowina
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Iris Panagiota Efthymiou
University of Greenwich, United KingdomSubmit your abstract Today
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands